Ministry of Health and Family Welfare

Update on National TB Elimination Programme


Centre scales up availability of molecular diagnostic facilities for TB patients

Regular assessments being conducted to evaluate stock positions of Anti-TB drugs

Posted On: 19 DEC 2023 6:52PM by PIB Delhi

As per the Global TB Report 2023, published by the World Health Organization, the estimated number of drug resistant TB in India has reduced by 21% from 1.4 lakhs in 2015 to 1.1 lakhs in 2022. The Government has scaled up the availability of molecular diagnostic facilities and thereby there has been an increase in the proportion of TB patients being screened for the presence of drug resistance. The State wise data of DR-TB cases for last three years and the current year so far, is placed as Annexure-I.

There has been regular supply of Anti-TB drugs to all the State/UTs from the central level under the National TB Elimination Programme (NTEP) throughout the year and regular assessments are conducted to evaluate the stock positions at various levels, from central warehouses to peripheral health institutes. Further, State/UTs have been provisioned with resources for local procurement for limited quantities as and when required to meet the emergent requirements.

The steps taken by government for early diagnosis and treatment of Drug Resistant TB are as under:

1) the availability of molecular diagnostics has been scaled up to 6196 Nucleic Acid Amplification Test (NAAT) machines to cover all districts of the country. In addition, 91 Line Probe Assay and 69 liquid culture testing laboratories have been established for diagnosis of multi drug resistance.

2) Universal Drug Susceptibility Testing (UDST) is implemented to ensure every diagnosed TB patient is tested to rule out drug resistance at the time of diagnosis.

3) Newer drugs like Bedaquiline and Delamanid have been introduced for management of drug resistant TB.

4) Decentralized DR-TB treatment services are offered through 792 DR-TB Centres across the country. 

 

The Union Minister of State for Health and Family Welfare, Dr. Bharati Pravin Pawar stated this in a written reply in the Rajya Sabha today.

 

****

Annexure-I

S.No

State-wise MDR/RR TB patients diagnosed  for 2020-2023*

State/Uts

MDR/RR-TB Diagnosed (2020)

MDR/RR-TB Diagnosed (2021)

MDR/RR-TB diagnosed (2022)

MDR/RR-TB diagnosed (Jan-Oct 2023)

1

Andaman & Nicobar Islands

51

41

35

35

2

Andhra Pradesh

1380

1513

1536

1038

3

Arunachal Pradesh

224

222

177

102

4

Assam

782

448

826

781

5

Bihar

2974

3240

4447

3715

6

Chandigarh

46

72

74

142

7

Chhattisgarh

316

376

450

359

8

Dadra and Nagar Haveli and Daman and Diu

42

40

22

25

9

Delhi

2024

1580

3081

3337

10

Goa

47

54

59

30

11

Gujarat

2822

2667

2784

2577

12

Haryana

1441

1283

2096

1729

13

Himachal Pradesh

209

207

238

186

14

Jammu & Kashmir

118

149

171

131

15

Jharkhand

860

896

1246

980

16

Karnataka

1498

1248

1755

1384

17

Kerala

187

186

282

281

18

Ladakh

10

4

4

4

19

Lakshadweep

0

0

1

0

20

Madhya Pradesh

3208

2359

3587

3218

21

Maharashtra

8085

9608

11562

8819

22

Manipur

65

75

96

43

23

Meghalaya

263

235

251

214

24

Mizoram

164

122

113

103

25

Nagaland

105

104

96

72

26

Odisha

461

439

568

428

27

Puducherry

13

19

23

79

28

Punjab

716

638

889

772

29

Rajasthan

3590

2474

4412

3816

30

Sikkim

231

243

205

116

31

Tamil Nadu

1377

1317

1688

1567

32

Telangana

1327

1152

1719

1277

33

Tripura

31

20

36

35

34

Uttar Pradesh

12329

12339

15566

13870

35

Uttarakhand

481

490

618

445

36

West Bengal

2202

2372

3088

2367

Data Source: Ni-kshay ; *Till 31st October, 2023

MV

HFW/ PQ /Update on NTEP /19December2023/1



(Release ID: 1988385) Visitor Counter : 3578


Read this release in: Urdu , Hindi